Skip to content
RushPR News – Lifestyle
Author:
Onco-Innovations Limited
Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
June 30, 2026
Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
June 30, 2026
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
June 26, 2026
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
June 25, 2026
Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
June 23, 2026
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
June 23, 2026
Onco-Innovations Announces Non-Brokered LIFE Offering
June 19, 2026
Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
June 19, 2026
Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
June 16, 2026
Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
June 9, 2026
1
2
3
Next Page
→